Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Galecto Inc (GLTO)

Galecto Inc (GLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Galecto Inc 75 STATE STREET SUITE 100 BOSTON MA 02109 DNK

www.galecto.com P: 45-7070-5210

Description:

Galecto Inc. is a clinical stage biotechnology company with advanced programs in fibrosis and cancer centered on galectin-3 and LOXL2. The Company's pipeline includes an inhaled galectin-3 modulator currently in Phase 2b for the potential treatment of idiopathic pulmonary fibrosis. Galecto Inc. is headquarters in Copenhagen, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 18,315
Enterprise Value, $K -3,155
Shares Outstanding, K 27,113
Annual Sales, $ 0 K
Annual Net Income, $ -38,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,470 K
EBIT, $ -39,900 K
EBITDA, $ -40,060 K
60-Month Beta 1.24
% of Insider Shareholders 12.10%
% of Institutional Shareholders 14.20%
Float, K 23,832
% Float 87.90%
Short Volume Ratio 0.48

Growth:

1-Year Return -61.18%
3-Year Return -87.47%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 03/08/24
Latest Earnings Date 05/03/24 [--]
Earnings Per Share ttm -1.45
EPS Growth vs. Prev Qtr 23.33%
EPS Growth vs. Prev Year 58.18%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GLTO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.68%
Return-on-Assets % -72.46%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.59
Book Value/Share 1.19
Interest Coverage -1.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar